Related references
Note: Only part of the references are listed.Novel techniques and targets in cardiovascular microRNA research
S. Dangwal et al.
CARDIOVASCULAR RESEARCH (2012)
Temporal and Spatial Expression of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases Following Myocardial Infarction
Merry L. Lindsey et al.
CARDIOVASCULAR THERAPEUTICS (2012)
TIMP3 Overexpression in Macrophages Protects From Insulin Resistance, Adipose Inflammation, and Nonalcoholic Fatty Liver Disease in Mice
Rossella Menghini et al.
DIABETES (2012)
Matrix Metalloproteinase-28 Deletion Amplifies Inflammatory and Extracellular Matrix Responses to Cardiac Aging
Yonggang Ma et al.
MICROSCOPY AND MICROANALYSIS (2012)
microRNA-9 Targets Matrix Metalloproteinase 14 to Inhibit Invasion, Metastasis, and Angiogenesis of Neuroblastoma Cells
Huanyu Zhang et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Liver-specific overexpression of matrix metalloproteinase 9 (MMP-9) in transgenic mice accelerates development of hepatocellular carcinoma
Florian R. Thieringer et al.
MOLECULAR CARCINOGENESIS (2012)
Direct regulation of membrane type 1 matrix metalloproteinase following myocardial infarction causes changes in survival, cardiac function, and remodeling
Juozas A. Zavadzkas et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2011)
Evidence for early fibrosis and increased airway resistance in bone marrow transplant recipient mice deficient in MMP12
Kristen A. England et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2011)
Myocardial Remodeling: Cellular and Extracellular Events and Targets
Jennifer A. Dixon et al.
ANNUAL REVIEW OF PHYSIOLOGY, VOL 73 (2011)
Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds
Joshua Roth et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Identification of MMP-9 specific microRNA expression profile as potential targets of anti-invasion therapy in glioblastoma multiforme
Wei Yan et al.
BRAIN RESEARCH (2011)
Diversity of Myocardial Interstitial Proteolytic Pathways Gene Deletion Reveals Unexpected Consequences
Francis G. Spinale
CIRCULATION (2011)
OxLDL up-regulates microRNA-29b, leading to epigenetic modifications of MMP-2/MMP-9 genes: a novel mechanism for cardiovascular diseases
Ku-Chung Chen et al.
FASEB JOURNAL (2011)
Inhibition of Matrix Metalloproteinase 14 (MMP-14)-mediated Cancer Cell Migration
Kevin Zarrabi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Matrix metalloproteinases: protective roles in cancer
Julie Decock et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)
Extracellular Matrix Composition and Remodeling in Human Abdominal Aortic Aneurysms: A Proteomics Approach
Athanasios Didangelos et al.
MOLECULAR & CELLULAR PROTEOMICS (2011)
Serum haptoglobin-matrix metalloproteinase 9 (Hp-MMP 9) complex as a biomarker of systemic inflammation in cattle
G. A. Bannikov et al.
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY (2011)
Effect of the oral application of a highly selective MMP-13 inhibitor in three different animal models of rheumatoid arthritis
Astrid Juengel et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
MicroRNA-27b Regulates the Expression of Matrix Metalloproteinase 13 in Human Osteoarthritis Chondrocytes
Nahid Akhtar et al.
ARTHRITIS AND RHEUMATISM (2010)
Pleiotropic roles of matrix metalloproteinases in tumor angiogenesis: Contrasting, overlapping and compensatory functions
Elena I. Deryugina et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2010)
Proteolytic and non-proteolytic roles of membrane type-1 matrix metalloproteinase in malignancy
Alex Y. Strongin
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2010)
The tissue inhibitors of metalloproteinases (TIMPs): An ancient family with structural and functional diversity
Keith Brew et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2010)
Matrix metalloproteinases: What do they not do? New substrates and biological roles identified by murine models and proteomics
David Rodriguez et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2010)
SAR studies of non-zinc-chelating MMP-13 inhibitors: Improving selectivity and metabolic stability
Donghong Amy Gao et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Matrix metalloproteinase-2 and myocardial oxidative stress injury: beyond the matrix
Arulmozhi D. Kandasamy et al.
CARDIOVASCULAR RESEARCH (2010)
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
Kai Kessenbrock et al.
CELL (2010)
MicroRNAs Add a New Dimension to Cardiovascular Disease
Eric M. Small et al.
CIRCULATION (2010)
Potential Therapeutic Targets for Cardiac Fibrosis TGFβ, Angiotensin, Endothelin, CCN2, and PDGF, Partners in Fibroblast Activation
Andrew Leask
CIRCULATION RESEARCH (2010)
Intracellular substrate cleavage: a novel dimension in the biochemistry, biology and pathology of matrix metalloproteinases
Benedicte Cauwe et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2010)
Matrix Metalloproteinase Inhibitors A Critical Appraisal of Design Principles and Proposed Therapeutic Utility
Gyoergy Dorman et al.
DRUGS (2010)
Novel selective MMP-13 inhibitors reduce collagen degradation in bovine articular and human osteoarthritis cartilage explants
Dorothea Piecha et al.
INFLAMMATION RESEARCH (2010)
Cardiac Restricted Overexpression of Membrane Type-1 Matrix Metalloproteinase Causes Adverse Myocardial Remodeling following Myocardial Infarction
Francis G. Spinale et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
TIMPs and cardiac remodeling: 'Embracing the MMP-independent-side of the family'
Davy Vanhoutte et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2010)
In vivo Matrix Metalloproteinase-7 Substrates Identified in the Left Ventricle Post-Myocardial Infarction Using Proteomics
Ying Ann Chiao et al.
JOURNAL OF PROTEOME RESEARCH (2010)
Modulatory effect of interleukin-1α on expression of structural matrix proteins, MMPs and TIMPs in human cardiac myofibroblasts: Role of p38 MAP kinase
Neil A. Turner et al.
MATRIX BIOLOGY (2010)
Proteomic analysis identifies in vivo candidate matrix metalloproteinase-9 substrates in the left ventricle post-myocardial infarction
Rogelio Zamilpa et al.
PROTEOMICS (2010)
A New Class of Potent Matrix Metalloproteinase 13 Inhibitors for Potential Treatment of Osteoarthritis Evidence of Histologic and Clinical Efficacy Without Musculoskeletal Toxicity in Rat Models
Vijaykumar M. Baragi et al.
ARTHRITIS AND RHEUMATISM (2009)
High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate
Janelle L. Lauer-Fields et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
Improving potency and selectivity of a new class of non-Zn-chelating MMP-13 inhibitors
Alexander Heim-Riether et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
microRNA-146b inhibits glioma cell migration and invasion by targeting MMPs
Hongping Xia et al.
BRAIN RESEARCH (2009)
Treatment with spironolactone for 24 weeks decreases the level of matrix metalloproteinases and improves cardiac function in patients with chronic heart failure of ischemic etiology
M. J. Li et al.
CANADIAN JOURNAL OF CARDIOLOGY (2009)
A novel and selective membrane type-1 matrix metalloproteinase (MT1-MMP) inhibitor reduces cancer cell motility and tumor growth
Juho Suojanen et al.
CANCER BIOLOGY & THERAPY (2009)
Selective Inhibition of Matrix Metalloproteinase-14 Blocks Tumor Growth, Invasion, and Angiogenesis
Laetitia Devy et al.
CANCER RESEARCH (2009)
Protective roles of matrix metalloproteinases From mouse models to human cancer
Carlos Lopez-Otin et al.
CELL CYCLE (2009)
Assessment of the Multiple-Biomarker Approach for Diagnosis of Myocardial Infarction in Patients Presenting with Symptoms Suggestive of Acute Coronary Syndrome
Fred S. Apple et al.
CLINICAL CHEMISTRY (2009)
Membrane-type 1 Matrix Metalloproteinase Regulates Macrophage-dependent Elastolytic Activity and Aneurysm Formation in Vivo
Wanfen Xiong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Identification of Specific Hemopexin-like Domain Residues That Facilitate Matrix Metalloproteinase Collagenolytic Activity
Janelle L. Lauer-Fields et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Molecular Imaging of Matrix Metalloproteinase Expression in Atherosclerotic Plaques of Mice Deficient in Apolipoprotein E or Low-Density-Lipoprotein Receptor
Satoru Ohshima et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Loss of TIMP3 Enhances Interstitial Nephritis and Fibrosis
Zamaneh Kassiri et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Membrane-bound FRET probe visualizes MMP12 activity in pulmonary inflammation
Amanda Cobos-Correa et al.
NATURE CHEMICAL BIOLOGY (2009)
Metalloproteinase MT5-MMP is an essential modulator of neuro-immune interactions in thermal pain stimulation
Alicia R. Folgueras et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Accurate targeting of activated macrophages based on synergistic activation of functional molecules uptake by scavenger receptor and matrix metalloproteinase
Hideyuki Suzuki et al.
ACS CHEMICAL BIOLOGY (2008)
Keratinocyte Expression of MMP3 Enhances Differentiation and Prevents Tumor Establishment
Lisa J. McCawley et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Molecular Imaging of Activated Matrix Metalloproteinases in Vascular Remodeling
Jiasheng Zhang et al.
CIRCULATION (2008)
Clinical implications of elevated serum interleukin-6, soluble CD40 ligand, metalloproteinase-9, and tissue inhibitor of metalloproteinase-1 in patients with acute ST-segment elevation myocardial infarction
Jing Tan et al.
CLINICAL CARDIOLOGY (2008)
Membrane-type MMPs enable extracellular matrix permissiveness and mesenchymal cell proliferation during embryogenesis
Joanne Shi et al.
DEVELOPMENTAL BIOLOGY (2008)
Macrophage roles following myocardial infarction
Jessica M. Lambert et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2008)
Selective modulation of matrix metalloproteinase 9 (MMP-9) functions via exosite inhibition
Janelle L. Lauer-Fields et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Extracellular matrix turnover and inflammatory markers independently predict functional status and outcome in chronic heart failure
Anca Radauceanu et al.
JOURNAL OF CARDIAC FAILURE (2008)
Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis
Jie Jack Li et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Characterization of an exosite binding inhibitor of matrix metalloproteinase 13
Lata T. Gooljarsingh et al.
PROTEIN SCIENCE (2008)
Human neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesis
Veronica C. Ardi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammation
Philippe Van Lint et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
The other side of MMPs: Protective roles in tumor progression
Michelle D. Martin et al.
CANCER AND METASTASIS REVIEWS (2007)
Individual matrix metalloproteinases control distinct transcriptional responses in airway epithelial cells infected with Pseudomonas aeruginosa
Sean Y. Kassim et al.
INFECTION AND IMMUNITY (2007)
Molecular structures and dynamics of the stepwise activation mechanism of a matrix metalloproteinase zymogen: Challenging the cysteine switch dogma
Gabriel Rosenblum et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2007)
Myocardial matrix remodeling and the matrix metalloproteinases: Influence on cardiac form and function
Francis G. Spinale
PHYSIOLOGICAL REVIEWS (2007)
Discovery and characterization of a novel inhibitor of matrix metalloprotease-13 that reduces cartilage damage in vivo without joint fibroplasia side effects
Adam R. Johnson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Establishment of an MT4-MMP-deficient mouse strain representing an efficient tracking system for MT4-MMP/MMP-17 expression in vivo using β-galactosidase
Akiko Rikimaru et al.
GENES TO CELLS (2007)
Triple-helical transition state analogues: A new class of selective matrix metalloproteinase inhibitors
Janelle Lauer-Fields et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2007)
Type I collagen is a genetic modifier of matrix metalloproteinase 2 in murine skeletal development
Mikala Egeblad et al.
DEVELOPMENTAL DYNAMICS (2007)
Cardiac matrix metalloproteinase-2 expression independently induces marked ventricular remodeling and systolic dysfunction
Marina R. Bergman et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Overexpression of MMP9 in macrophages attenuates pulmonary fibrosis induced by bleomycin
Sandra Cabrera et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2007)
Increased levels of interleukin-6 and matrix metalloproteinase-9 are of cardiac origin in acute coronary syndrome
Jun Shu et al.
SCANDINAVIAN CARDIOVASCULAR JOURNAL (2007)
Potent, selective pyrimidinetrione-based inhibitors of MMP-13
Lawrence A. Reiter et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Tissue inhibitor of metalloproteinases 4 (TIMP4) is involved in inflammatory processes of human cardiovascular pathology
Ilpo Koskivirta et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2006)
Inflammation in atherosclerosis - Visualizing matrix metalloproteinase action in macrophages in vivo
Jun-o Deguchi et al.
CIRCULATION (2006)
Matrix metalloproteinase-7 affects connexin-43 levels, electrical conduction, and survival after myocardial infarction
ML Lindsey et al.
CIRCULATION (2006)
Tissue inhibitor of metalloproteinase-1 (TIMP-1) is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction
Erdal Cavusoglu et al.
AMERICAN HEART JOURNAL (2006)
Bone marrow molecular alterations after myocardial infarction: Impact on endothelial progenitor cells
T Thum et al.
CARDIOVASCULAR RESEARCH (2006)
Matrix metalloproteinases play an active role in Wnt1-induced mammary tumorigenesis
L Blavier et al.
CANCER RESEARCH (2006)
Tumour microenvironment - Opinion - Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy
CM Overall et al.
NATURE REVIEWS CANCER (2006)
The importance of estimating the therapeutic index in the development of matrix metalloproteinase inhibitors
JT Peterson
CARDIOVASCULAR RESEARCH (2006)
The TACE zymogen - Re-examining the role of the cysteine switch
ME Milla et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2006)
Matrix metalloproteinases: roles in cancer and metastasis
B Fingleton
FRONTIERS IN BIOSCIENCE-LANDMARK (2006)
Resistance of collagenase-2 (matrix metalloproteinase-8)-deficient mice to TNF-induced lethal hepatitis
P Van Lint et al.
JOURNAL OF IMMUNOLOGY (2005)
Myocardial ischemia induces interleukin-6 and tissue factor production in patients with coronary artery disease - A dobutamine stress echocardiography study
I Ikonomidis et al.
CIRCULATION (2005)
Noninvasive targeted imaging of matrix metalloproteinase activation in a murine model of postinfarction remodeling
HL Su et al.
CIRCULATION (2005)
Matrix metalloproteinase-13/collagenase-3 deletion promotes collagen accumulation and organization in mouse atherosclerotic plaques
JO Deguchi et al.
CIRCULATION (2005)
Cardiac morphogenesis: Matrix metalloproteinase coordination of cellular mechanisms underlying heart tube formation and directionality of looping
KK Linask et al.
DEVELOPMENTAL DYNAMICS (2005)
Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors
S Lee et al.
JOURNAL OF CELL BIOLOGY (2005)
Matrix metalloproteinases as therapeutic targets in cancer
P Vihinen et al.
CURRENT CANCER DRUG TARGETS (2005)
Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14
JA Blagg et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
A key role for mast cell chymase in the activation of pro-matrix metalloprotease-9 and pro-matrix metalloprotease-2
E Tchougounova et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Heterogeneous effects of tissue inhibitors of matrix metalloproteinases on cardiac fibroblasts
JD Lovelock et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
Structural basis for the highly selective inhibition of MMP-13
CK Engel et al.
CHEMISTRY & BIOLOGY (2005)
Accelerated LV remodeling after myocardial infarction in TIMP-1-deficient mice: effects of exogenous MMP inhibition
JS Ikonomidis et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
Differential expression of three matrix metalloproteinases, MMP-19, MMP-26, and MMP-28, in normal and inflamed intestine and colon cancer
VO Bister et al.
DIGESTIVE DISEASES AND SCIENCES (2004)
Matrix metalloproteinase 1 interacts with neuronal integrins and stimulates dephosphorylation of Akt
K Conant et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Activities of the matrix metalloproteinase stromelysin-2 (MMP-10) in matrix degradation and keratinocyte organization in wounded skin
M Krampert et al.
MOLECULAR BIOLOGY OF THE CELL (2004)
Processing, shedding, and endocytosis of membrane type 1-matrix metalloproteinase (MT1-MMP)
P Osenkowski et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2004)
Anoxia-reoxygenation stimulates collagen type-1 and MMP-1 expression in cardiac fibroblasts -: Modulation by the PPAR-γ ligand pioglitozone
K Chen et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2004)
Tumor cell traffic through the extracellular matrix is controlled by the membrane-anchored collagenase MT1-MMP
F Sabeh et al.
JOURNAL OF CELL BIOLOGY (2004)
TIMP-3 deficiency leads to dilated cardiomyopathy
PWM Fedak et al.
CIRCULATION (2004)
Characterization of the distinct collagen binding, helicase and cleavage mechanisms of matrix metalloproteinase 2 and 14 (gelatinase A and MT1-MMP) - The differential roles of the MMP hemopexin C domains and the MMP-2 fibronectin type II modules in collagen triple helicase activities
EM Tam et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Overexpression of human matrix metalloproteinase-12 enhances the development of inflammatory arthritis in transgenic
XF Wang et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosis
A Bar-Or et al.
BRAIN (2003)
Expression of membrane type-4 matrix metalloproteinase (metalloproteinase-17) by human eosinophils
MC Gauthier et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2003)
Type I collagen-induced MMP-2 activation coincides with up-regulation of membrane type 1-matrix metalloproteinase and TIMP-2 in cardiac fibroblasts
C Guo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Neutrophil granules and secretory vesicles in inflammation
M Faurschou et al.
MICROBES AND INFECTION (2003)
Regulation of matrix metalloproteinases: An overview
S Chakraborti et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2003)
Deficiency of TIMP-1 exacerbates LV remodeling after myocardial infarction in mice
EEJM Creemers et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2003)
Localization and expression of tissue inhibitor of metalloproteinase-4 in the immature gonadotropin-stimulated and adult rat ovary
KS Simpson et al.
BIOLOGY OF REPRODUCTION (2003)
Enamelysin (matrix metalloproteinase 20)-deficient mice display an amelogenesis imperfecta phenotype
JJ Caterina et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Increased expression of membrane type 3-matrix metalloproteinase in human atherosclerotic plaque - Role of activated macrophages and inflammatory cytokines
H Uzui et al.
CIRCULATION (2002)
Matrix metalloproteinase 9 (MMP-9/gelatinase B) proteolytically cleaves ICAM-1 and participates in tumor cell resistance to natural killer cell-mediated cytotoxicity
E Fiore et al.
ONCOGENE (2002)
Substrate binding of gelatinase B induces its enzymatic activity in the presence of intact propeptide
GA Bannikov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Cancer therapy - Matrix metalloproteinase inhibitors and cancer: Trials and tribulations
LM Coussens et al.
SCIENCE (2002)
Tumor necrosis factor-alpha converting enzyme
RA Black
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2002)
New functions for the matrix metalloproteinases in cancer progression
M Egeblad et al.
NATURE REVIEWS CANCER (2002)
Analysis of two matrix metalloproteinase inhibitors and their metabolites for induction of phospholipidosis in rat and human hepatocytes
RJ Gum et al.
BIOCHEMICAL PHARMACOLOGY (2001)
The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis
J Oh et al.
CELL (2001)
Matrix metalloproteinases regulate neutrophil-endothelial cell adhesion through generation of endothelin-1[1-32]
C Fernandez-Patron et al.
FASEB JOURNAL (2001)
Upregulation and differential expression of matrilysin (MMP-7) and metalloelastase (MMP-12) and their inhibitors TIMP-1 and TIMP-3 in Barrett's oesophageal adenocarcinoma
MT Salmela et al.
BRITISH JOURNAL OF CANCER (2001)
Osteopontin, a novel substrate for matrix metalloproteinase-3 (stromelysin-1) and matrix metalloproteinase-7 (matrilysin)
R Agnihotri et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Subcellular distribution and cytokine- and chemokine-regulated secretion of leukolysin/MT6-MMP/MMP-25 in neutrophils
TB Kang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Substrate hydrolysis by matrix metalloproteinase-9
SJ Kridel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Tissue inhibitor of metalloproteinases-2 (TIMP-2) suppresses TKR-growth factor signaling independent of metalloproteinase inhibition
SE Hoegy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Structure-based design of a novel, potent, and selective inhibitor for MMP-13 utilizing NMR spectroscopy and computer-aided molecular design
JM Chen et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2000)
Effects of gene deletion of the tissue inhibitor of the matrix metalloproteinase-type 1 (TIMP-1) on left ventricular geometry and function in mice
L Roten et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2000)
Share Paper
